• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液凝固过程中,接触因子(HG,凝血因子XII)、血浆凝血活酶前体(PTA,凝血因子XI)、血浆前激肽释放酶(PK,弗莱彻因子)和高分子量激肽原(HMW-K,菲茨杰拉德因子)之间的相互作用。

Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.

作者信息

Saito H, Ratnoff O D

出版信息

Adv Exp Med Biol. 1979;120B:61-70.

PMID:517254
Abstract

Studies of plasmas from individuals with Hageman trait (factor XII deficiency), plasma thromboplastin antecedent (PTA, factor XI) deficiency, Fletcher trait (plasma prekallikrein deficiency) and Fitzgerald trait (high molecular weight-kininogen deficiency) have revealed the importance of these proteins in blood coagulation. The interactions among them, however, are not fully elucidated. We have studied these reactions by two different approaches. (1) In a purified system, high molecular weight kininogen was absolutely required for activation of PTA by HF and ellagic acid (EA). The yield of activated PTA was proportional to the amount of HF, HMW-K, and PTA in the mixtures, suggesting that these three proteins may form a complex in the presence of EA. (2) In experiments with whole plasma, we took advantage of the adsorption of EA to Sephadex gels. When normal plasma or plasma deficient in HF, PK, HMW-K or PTA was exposed to Sephadex-EA and was separated by centrifugation, each supernatant plasma except that deficient in HF shortened the prolonged partial thromboplastin time (PTT) of HF-deficient plasma. Plasma simultaneously depleted of HMW-K, PK and PTA also shortened the PTT of HF-deficient plasma and of plasma depleted of HF and PK, but had virtually no procoagulant effect upon the PTT of plasma depleted of HF and MHW-K. Thus, exposure of HF in plasma to Sephadex-EA appeared to generate a clot-promoting form of HF in the absence of other clotting factors, but its expression required the presence of HMW-K.

摘要

对具有哈格曼特征(因子Ⅻ缺乏)、血浆凝血活酶前体(PTA,因子Ⅺ)缺乏、弗莱彻特征(血浆前激肽释放酶缺乏)和菲茨杰拉德特征(高分子量激肽原缺乏)个体的血浆研究揭示了这些蛋白质在血液凝固中的重要性。然而,它们之间的相互作用尚未完全阐明。我们通过两种不同的方法研究了这些反应。(1)在纯化系统中,高分子量激肽原是HF和鞣花酸(EA)激活PTA所绝对必需的。激活的PTA产量与混合物中HF、HMW-K和PTA的量成正比,这表明这三种蛋白质在EA存在下可能形成复合物。(2)在全血实验中,我们利用了EA对葡聚糖凝胶的吸附作用。当正常血浆或缺乏HF、PK、HMW-K或PTA的血浆与葡聚糖-EA接触并通过离心分离时,除缺乏HF的血浆外,每种上清血浆都缩短了缺乏HF血浆的部分凝血活酶时间(PTT)延长。同时缺乏HMW-K、PK和PTA的血浆也缩短了缺乏HF血浆以及缺乏HF和PK血浆的PTT,但对缺乏HF和MHW-K血浆的PTT几乎没有促凝作用。因此,血浆中的HF与葡聚糖-EA接触似乎在没有其他凝血因子的情况下产生了一种促进凝血的HF形式,但其表达需要HMW-K的存在。

相似文献

1
Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.血液凝固过程中,接触因子(HG,凝血因子XII)、血浆凝血活酶前体(PTA,凝血因子XI)、血浆前激肽释放酶(PK,弗莱彻因子)和高分子量激肽原(HMW-K,菲茨杰拉德因子)之间的相互作用。
Adv Exp Med Biol. 1979;120B:61-70.
2
Purification of high molecular weight kininogen and the role of this agent in blood coagulation.高分子量激肽原的纯化及其在血液凝固中的作用。
J Clin Invest. 1977 Sep;60(3):584-94. doi: 10.1172/JCI108810.
3
Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.菲茨杰拉德性状中的激肽原缺乏:高分子量激肽原在凝血和纤维蛋白溶解中的作用。
J Lab Clin Med. 1976 Feb;87(2):327-37.
4
Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.接触因子、血浆前激肽释放酶、高分子量激肽原和血浆凝血活酶前体之间的相互作用。
Proc Natl Acad Sci U S A. 1979 Feb;76(2):958-61. doi: 10.1073/pnas.76.2.958.
5
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.人凝血因子Ⅻ的激活与功能。高分子量激肽原和前激肽释放酶的作用。
J Clin Invest. 1977 Jul;60(1):18-31. doi: 10.1172/JCI108754.
6
Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.人高分子量激肽原的裂解显著增强其凝血活性。该分子作为前辅因子存在的证据。
J Clin Invest. 1984 Apr;73(4):954-62. doi: 10.1172/JCI111319.
7
Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.高分子量激肽原对哈格曼因子片段功能的增强作用。
J Clin Invest. 1977 Jul;60(1):7-17. doi: 10.1172/JCI108770.
8
The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.前激肽释放酶和高分子量激肽原在硫酸脑苷脂及其他试剂对哈格曼因子(因子XII)的接触激活中的作用。
J Lab Clin Med. 1983 Oct;102(4):487-99.
9
Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.藤原特质中通过因子 XII 的接触激活异常:高分子量和低分子量激肽原均缺乏,且前激肽释放酶水平较低。
Tohoku J Exp Med. 1981 Jan;133(1):67-80. doi: 10.1620/tjem.133.67.
10
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.接触激活过程中人类凝血因子Ⅻ的结合与裂解特性。正常血浆与缺乏因子Ⅺ、前激肽释放酶或高分子量激肽原的血浆的比较。
J Clin Invest. 1977 Jun;59(6):1167-75. doi: 10.1172/JCI108741.

引用本文的文献

1
Human plasma kallikrein-kinin system: physiological and biochemical parameters.人血浆激肽释放酶-激肽系统:生理和生化参数
Cardiovasc Hematol Agents Med Chem. 2009 Jul;7(3):234-50. doi: 10.2174/187152509789105444.